BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14984938)

  • 1. Differential expression of interleukins IL-13 and IL-15 in normal ovarian tissue and ovarian carcinomas.
    Ripley D; Shoup B; Majewski A; Chegini N
    Gynecol Oncol; 2004 Mar; 92(3):761-8. PubMed ID: 14984938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-11 receptor expression in primary ovarian carcinomas.
    Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
    Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein and mRNA expression of aquaporin-1 in epithelial ovarian tumors and its clinic significance].
    Yang JH; Shi YF; Cheng Q; Qian YL
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):623-6. PubMed ID: 16202320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IL-10 in human normal and cancerous ovarian tissues and cells.
    Rabinovich A; Medina L; Piura B; Huleihel M
    Eur Cytokine Netw; 2010 Jun; 21(2):122-8. PubMed ID: 20430716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of aquaporin-5 in the epithelial ovarian tumors.
    Yang JH; Shi YF; Cheng Q; Deng L
    Gynecol Oncol; 2006 Feb; 100(2):294-9. PubMed ID: 16242760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas.
    Ivarsson K; Ekerydh A; Fyhr IM; Janson PO; Brännström M
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):777-84. PubMed ID: 10993102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells.
    Roberts M; Luo X; Chegini N
    Mol Hum Reprod; 2005 Oct; 11(10):751-60. PubMed ID: 16254005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct patterns of expression of interleukin-1 alpha and beta by normal and cancerous human ovarian tissues.
    Huleihel M; Maymon E; Piura B; Prinsloo I; Benharroch D; Yanai-Inbar I; Glezerman M
    Eur Cytokine Netw; 1997 Jun; 8(2):179-87. PubMed ID: 9262967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMUP-1 and IMUP-2 genes are up-regulated in human ovarian epithelial tumors.
    Kim JK; An HJ; Kim NK; Ahn JY; Kim KS; Kang YJ; Ko JJ; Oh D; Lee C; Kim SJ; Cha KY
    Anticancer Res; 2003; 23(6C):4709-13. PubMed ID: 14981917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
    Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion.
    Chegini N; Ma C; Roberts M; Williams RS; Ripps BA
    J Reprod Immunol; 2002; 56(1-2):93-110. PubMed ID: 12106886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma].
    Chen CL; Yan X; Gao YN; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):770-4. PubMed ID: 16324253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated aromatase expression correlates with cervical carcinoma progression.
    Veerapaneni P; Kirma N; Nair HB; Hammes LS; Hall KL; Tekmal RR
    Gynecol Oncol; 2009 Sep; 114(3):496-500. PubMed ID: 19555998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
    Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.
    Shigemasa K; Underwood LJ; Beard J; Tanimoto H; Ohama K; Parmley TH; O'Brien TJ
    J Soc Gynecol Investig; 2000; 7(6):358-62. PubMed ID: 11111072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mRNA expressions of sialyltransferases in ovarian cancers.
    Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
    Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.